Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
Why the study?
Cardiorenal syndrome clinicopathological descriptions have continuously evolved over the past decade, prompting an updated overview of its epidemiology, pathogenesis, and management.
Design
AHA scientific statement
Authors
Discussion
Loading...
Member takes
Implication
Elevated mortality risk with acute cardiorenal syndrome type 1 supports vigilant monitoring in CKD; reinforces consensus guidelines but leaves prospective validation open.
PICO
P
Population
cardiorenal syndrome
This AHA scientific statement provides a comprehensive consensus overview of the classification, pathophysiology, diagnostic tools, and therapeutic strategies for cardiorenal syndrome.
Cite This Study
Rangaswami et al. (2019) studied cardiorenal syndrome. The acute cardiorenal syndrome type 1 phenotype was associated with a higher risk of death compared to chronic kidney disease without cardiorenal syndrome, with a hazard ratio of 3.13 (95% CI, 2.72–3.61).